Drug Shortage Report for INTEGRILIN

Last updated on 2022-03-23 History
Report ID 149545
Drug Identification Number 02240352
Brand name INTEGRILIN
Common or Proper name Eptifibatide Injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) EPTIFIBATIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1
ATC code B01AC
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date 2021-11-26
Actual start date 2021-11-24
Estimated end date 2022-03-29
Actual end date 2022-03-22
Shortage status Resolved
Updated date 2022-03-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2022-03-23 English Compare
v18 2022-03-22 French Compare
v17 2022-03-22 English Compare
v16 2022-02-17 French Compare
v15 2022-02-17 English Compare
v14 2022-02-02 French Compare
v13 2022-02-02 English Compare
v12 2022-01-05 French Compare
v11 2022-01-05 English Compare
v10 2021-12-08 French Compare
v9 2021-12-08 English Compare
v8 2021-11-25 English Compare
v7 2021-11-24 French Compare
v6 2021-11-24 English Compare
v5 2021-11-22 French Compare
v4 2021-11-22 English Compare
v3 2021-11-18 French Compare
v2 2021-11-18 English Compare
v1 2021-11-18 English Compare

Showing 1 to 19 of 19